BNY Mellon (BNY)
NYSEFinancialsInvestment - Banking & Investment ServicesSnapshot 2026-09-04
$164.84+0.31%
Close 2026-09-04 · 1-day change
NYSEFinancialsInvestment - Banking & Investment ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
BNY Mellon grows revenue steadily with $5.4 billion in Q1 2026. EPS rose from $1.58 to $2.24 in one year. The company plans to increase its dividend by 19%, showing strong cash returns. Profitability and growth are stable with low risk.
Revenue growth could slow below analyst expectations. EPS growth may stall if market conditions worsen. Dividend increases depend on board approval and sustained cash flow.
The stock trades about 24% above our fair value near $123. Analysts expect about 9% revenue growth. Our fair value is 16% below the Street median, so the market prices in strong growth and dividend increases that may be optimistic.
Breaks if: Dividend increase to $0.63 not approved or delayed beyond Q3 2026
Breaks if: EPS falls below $2.24 in Q1 2026
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable compounder with a focus on revenue and earnings growth. The current thesis state is intact, supported by recent financial performance that remains strong relative to its industry.
The market appears to price BNY at a premium compared to peers, indicating expectations for continued performance. However, the valuation is stretched, reflecting a gap between current expectations and the underlying fundamentals.
Management is on track to achieve strong revenue growth and consistent earnings per share growth, with recent results showing positive trends. However, the earnings quality remains fragile, which could impact future performance.
The thesis hinges on the performance of sector bellwethers like IBKR, BK, and SF. If these companies continue to report strong earnings, it could support BNY's growth. Conversely, any negative guidance from these peers could pose risks to BNY's outlook.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Focus on increasing diluted earnings per share through operational leverage and revenue growth.
Stated as a priority in 2 of last 2 quarters. Diluted EPS rose from $2.24 in 2026-Q1 to $2.45 in 2026-Q2, a 27% increase year-over-year. This consistent EPS growth matches management's stated focus and reflects delivery on this priority.
“Diluted EPS increased 27% year-over-year to $2.45 in 2Q26.”
“Diluted EPS was $2.24 in 1Q26, up from $1.93 in 2Q25.”
Breaks if: revenue falls below $5.4 billion in Q1 2026
In the next 1 to 3 years, BNY's performance will depend on its ability to maintain growth amid sector dynamics and manage earnings quality. Not investment advice.